Product/Composition:- | Miconazole Vaginal Creams and Suppositories |
---|---|
Strength:- | 2%, 120 mg (vaginal suppositories) |
Form:- | Vaginal Creams and Suppositories |
Reference Brands:- | Monistat(US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Miconazole vaginal creams and suppositories inhibit fungal cytochrome P450 14α-demethylase, disrupting ergosterol synthesis and damaging fungal cell membranes. They effectively treat vaginal candidiasis, offering benefits like targeted local therapy, rapid symptom relief, minimal systemic absorption, and high safety, making them a reliable and convenient treatment option.
Miconazole vaginal creams and suppositories are approved in the EU and US for treating vaginal candidiasis. In the EU, brands like Daktarin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA-approved products like Monistat are based on comprehensive clinical data and pharmacovigilance. Both regions require detailed dossiers for approval and continued safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We help facilitate efficient market entry for miconazole vaginal formulations, ensuring adherence to European and American standards for safe, effective antifungal therapy.